Related Experiment Videos
Experimental chemotherapeutic agents for the treatment of colorectal carcinoma
1Division of Medical Oncology, Johns Hopkins Oncology Center, Baltimore, Maryland, USA.
Hematology/Oncology Clinics of North America
|August 1, 1997
Abstract:
Colorectal cancer is the third leading cause of cancer mortality for men and women in the United States. For the past 40 years fluorouracil has been the only agent with significant activity in this disease. More recently, advances in our understanding of the molecular biology of cancer have permitted the development of effective new agents for this disease. This article examines the current and future status of these new agents.